SERum-bank for PANcreatic Cancer

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE SAINT ETIENNE · May 4, 2020

Keywords

ClinConnect Summary

This clinical trial, called the SERum-bank for PANcreatic Cancer, is focused on improving early detection of pancreatic cancer, specifically a type called adenocarcinoma. Early diagnosis (when the cancer is less than 2 cm) significantly increases the chances of successful treatment. Unfortunately, most pancreatic cancer cases are diagnosed late, which makes them harder to treat. The study aims to explore blood markers as a simple and effective way to detect the disease earlier.

To participate, individuals must be at least 18 years old and have been diagnosed with adenocarcinoma, regardless of the cancer stage, but not if the tumor can be removed immediately without further testing. There is also a control group for individuals aged 40 and older who are undergoing digestive endoscopy for reasons other than cancer. Participants will provide blood samples that researchers will use to study potential markers for early detection. This trial is currently recruiting participants, and joining might help advance understanding of pancreatic cancer, potentially benefiting future patients.

Gender

ALL

Eligibility criteria

• • ADENOCARCINOMA GROUP
• Inclusion Criteria:
• • Documented adenocarcinoma (cytology / anatomopathology), all stages, except if the tumor is immediately resectable and does not require preoperative cytological evidence. In this case, the inclusion and the first collection of the sero bank is done preoperatively. The diagnostic confirmation will therefore be made post-operatively at the risk of being excluded in the event of a different diagnosis.
• • At the start of treatment (before surgery / 1st course of chemotherapy)
• • Age ≥ 18 years
• • Patient affiliated or entitled to a social security system
• Exclusion Criteria:
• • Patient refusal
• • Acute renal failure
• • Child-Pugh B or C cirrhosis
• • Patient under guardianship or curators
• • Other synchronous cancer or history of cancer \<5 years
• • Language barrier
• • CONTROL GROUP
• Inclusion Criteria:
• • Age ≥ 40 years
• • Patient affiliated or entitled to a social security system
• • Digestive endoscopy for any reason other than cancer or chronic inflammatory bowel disease
• Exclusion Criteria:
• • Patient refusal
• • Acute renal failure
• • Child-Pugh B or C cirrhosis
• • Patient under guardianship or curators
• • Other synchronous cancer or history of cancer \<5 years